Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NIAID

GITR Ligand and Antibodies and Uses Thereof

  • Read more about GITR Ligand and Antibodies and Uses Thereof
US Application 60/472,844
Filed on 2003-05-24

Recovery of Recombinant Human Metapneumovirus (HMPV) from cDNA and Use of Recombinant HMPV in Immunogenic Compositions and as Vectors to Elicit Immune Responses Against HMPV and Other Human Pathogens

  • Read more about Recovery of Recombinant Human Metapneumovirus (HMPV) from cDNA and Use of Recombinant HMPV in Immunogenic Compositions and as Vectors to Elicit Immune Responses Against HMPV and Other Human Pathogens
US Application 60/478,667
Filed on 2003-06-13

The Generation and Use of Recombinant Forms of the Vaccinia Virus L1R and A33R Proteins as a Subunit Vaccine

  • Read more about The Generation and Use of Recombinant Forms of the Vaccinia Virus L1R and A33R Proteins as a Subunit Vaccine
US Application 60/451,337
Filed on 2004-02-27

Inhibition of HIV-1 Replication by Disrupting the Processing of the Viral Gag Capsid (CA) Protein from the Ca-Spacer Peptide 1 Protein Processor

  • Read more about Inhibition of HIV-1 Replication by Disrupting the Processing of the Viral Gag Capsid (CA) Protein from the Ca-Spacer Peptide 1 Protein Processor
US Application 60/443,180
Filed on 2003-01-29

Identification of a Region of Merozoite Surface Protein 1 (MSP-1) Necessary for Protective Immunity

  • Read more about Identification of a Region of Merozoite Surface Protein 1 (MSP-1) Necessary for Protective Immunity
US Application 60/503,076
Filed on 2003-12-09

Assays For Assembly Of Ebola Virus Nucleocapsids

  • Read more about Assays For Assembly Of Ebola Virus Nucleocapsids
US Application 60/451,317
Filed on 2003-02-28

Antibodies Against The Amino Terminus Region Of Circumsporozoite Protein Prevent The Onset Of Malaria Infection

  • Read more about Antibodies Against The Amino Terminus Region Of Circumsporozoite Protein Prevent The Onset Of Malaria Infection
US Application 60/532,676
Filed on 2003-12-23

3'GENOMIC PROMOTER REGION AND POLYMERASE GENE MUTATIONS RESPONSIBLE FOR ATTENUATION IN VIRUSES OF THE ORDER DESIGNATED MONONEGAVIRALES

  • Read more about 3'GENOMIC PROMOTER REGION AND POLYMERASE GENE MUTATIONS RESPONSIBLE FOR ATTENUATION IN VIRUSES OF THE ORDER DESIGNATED MONONEGAVIRALES
US Application 60/026,823
Filed on 1996-09-27

CD25+ Differential Markers and Uses Thereof

  • Read more about CD25+ Differential Markers and Uses Thereof
US Application 60/304,827
Filed on 2001-07-12

Attenuated Respiratory Syncytial Viruses

  • Read more about Attenuated Respiratory Syncytial Viruses
US Application 60/059,552
Filed on 1997-09-19

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 96
  • Page 97
  • Page 98
  • Page 99
  • Page 100
  • Page 101
  • Page 102
  • Page 103
  • Page 104
  • …
  • Next page ››
  • Last page Last »
Subscribe to NIAID
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health